» Articles » PMID: 8307257

The Development of Hyperglycaemia in Patients with Insulin-resistant Generalized Lipoatrophic Syndromes

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1993 Dec 1
PMID 8307257
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Insulin resistance is present in patients suffering from lipoatrophic syndromes long before the onset of diabetes mellitus. Thus, the decreased peripheral glucose disposal may not be the only mechanism of hyperglycaemia. The kinetic parameters of glucose homeostasis were evaluated in six young females aged 15, 16, 18, 19 and 24 years with generalized lipoatrophy; one patient was studied both at 12 and 15 years. Insulin resistance was evaluated in vivo by the hyperinsulinaemic euglycaemic clamp (3-4 insulin infusion rates from 1 to 100 mU/kg.min). All patients showed a rightward shift of the dose-response curve, indicating decreased insulin sensitivity. In two patients, maximal glucose disposal was moderately decreased, while in five patients it was dramatically reduced (3.6-6.9 mg/kg.min). Fasting plasma glucose was variable (4.3-18.3 mmol/l) and did not correlate with peripheral glucose disposal rates. Hepatic glucose production, measured by infusion of [6,6-2H] glucose, varied from 1.7 to 8.3 mg/kg.min and was significantly correlated with fasting plasma glucose. The overproduction of glucose despite basal hyperinsulinism suggested hepatic insulin resistance, which was confirmed by the abnormal response to constant unlabelled glucose infusion (2 mg/kg.min) in five patients. In conclusion, impaired glucose tolerance seems to develop in generalized lipoatrophy with aggravated peripheral insulin resistance. The present data show that fasting hyperglycaemia is mainly the consequence of increased hepatic glucose production.

Citing Articles

Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.

Guettier J, Park J, Cochran E, Poitou C, Basdevant A, Meier M Clin Endocrinol (Oxf). 2007; 68(4):547-554.

PMID: 18076675 PMC: 2578870. DOI: 10.1111/j.1365-2265.2007.03095.x.

References
1.
BOWEN H, Moorhouse J . Glucose turnover and disposal in maturity-onset diabetes. J Clin Invest. 1973; 52(12):3033-45. PMC: 302578. DOI: 10.1172/JCI107502. View

2.
Lawrence R . Lipodystrophy and hepatomegaly, with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin. Lancet. 2010; 1(6403):724 passim. View

3.
Keenan B, Kirland R, Garber A, Rubenstein A, Holcombe J, Potts V . The effect of diet upon carbohydrate metabolism, insulin resistance, and blood pressure in congenital total lipoatrophic diabetes. Metabolism. 1980; 29(12):1214-24. DOI: 10.1016/0026-0495(80)90148-1. View

4.
Farese R, Standaert M, Arnold T, Yu B, Ishizuka T, Hoffman J . The role of protein kinase C in insulin action. Cell Signal. 1992; 4(2):133-43. DOI: 10.1016/0898-6568(92)90077-l. View

5.
OSEID S . Studies in congenital generalized lipodystrophy (Seip-Berardinelli syndrome). I. Development of diabetes. Acta Endocrinol (Copenh). 1973; 72(3):475-94. DOI: 10.1530/acta.0.0720475. View